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Abstract
Objective—To estimate the percentage of infants with large birth size attributable to excess 
gestational weight gain (GWG), independent of prepregnancy body mass index, among mothers 
with preexisting diabetes mellitus (PDM).
Study design—We analyzed 2004–2008 Florida linked birth certificate and maternal hospital 
discharge data of live, term (37–41 weeks) singleton deliveries (N = 641,857). We calculated 
prevalence of large-for-gestational age (LGA) (birth weight-for-gestational age ≥ 90th percentile) 
and macrosomia (birth weight > 4500 g) by GWG categories (inadequate, appropriate, or excess). 
We used multivariable logistic regression to estimate the relative risk (RR) of large birth size 
associated with excess compared to appropriate GWG among mothers with PDM. We then 
estimated the population attributable fraction (PAF) of large birth size due to excess GWG among 
mothers with PDM (n = 4427).
Results—Regardless of diabetes status, half of mothers (51.2%) gained weight in excess of 
recommendations. Large birth size was higher in infants of mothers with PDM than in infants of 
mothers without diabetes (28.8% versus 9.4% for LGA, 5.8% versus 0.9% for macrosomia). 
Among women with PDM, the adjusted RR of having an LGA infant was 1.7 (95% CI 1.5, 1.9) for 
women with excess GWG compared to those with appropriate gain; the PAF was 27.7% (95% CI 
22.0, 33.3). For macrosomia, the adjusted RR associated with excess GWG was 2.1 (95% CI 1.5, 
2.9) and the PAF was 38.6% (95% CI 24.9, 52.4).
Conclusion—Preventing excess GWG may avert over one-third of macrosomic term infants of 
mothers with PDM. Effective strategies to prevent excess GWG are needed.
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1. Introduction
The standard definition for preexisting diabetes mellitus (PDM) is any diabetes diagnosed 
prior to pregnancy (including both type 1 and type 2 diabetes). From 1993 to 2009, the 
prevalence of PDM among pregnant women increased 45%, from 0.62 to 0.90 per 100 
deliveries, mainly due to the rise in type 2 diabetes (Correa et al., 1993–2009). Women with 
PDM are at increased risk of adverse pregnancy outcomes including stillbirth, congenital 
anomalies, neonatal hypoglycemia, or large birth size (i.e., large for gestational age [LGA] 
(birth weight at or above 90th percentile) or macrosomia (birth weight > 4500 g)) (Correa et 
al., 2008). Studies have shown that the risk of large birth size remains high in women with 
PDM even when glucose levels are well controlled and within normal limits during 
pregnancy (Evers et al., 2002).
Infants born too large are at greater risk for birth trauma, longer hospital stays, postpartum 
hemorrhage for the mother, and neonatal death (Weissmann-Brenner et al., 2012). Large 
birth size also elevates the risk of adverse metabolic outcomes later in life, including higher 
risk for metabolic diseases such as obesity, dyslipidemia, hypertension, and type 2 diabetes 
(Schellong et al., 2012). Further, evidence suggests that mothers who themselves were LGA 
are more likely to deliver an LGA offspring, perpetuating a cycle of adverse metabolic and 
reproductive health outcomes (Costa e Silva et al., 2015).
High prepregnancy body mass index (BMI), excess gestational weight gain (GWG) and 
diabetes mellitus are risk factors for delivering a large baby. In 2009, the Institute of 
Medicine (IOM) published revised guidelines for appropriate GWG by BMI to promote a 
healthy pregnancy and thereby reducing adverse health outcomes and optimizing birth 
weight (IOM (Institute of Medicine) & NRC (National Research Council), 2009). In 2010–
2011, 47.2% of women gained gestational weight in excess of these guidelines in 28 states 
(Deputy et al., 2015). We have previously shown that approximately one third of LGA births 
may be prevented if women achieved appropriate GWG, independent of prepregnancy BMI 
and gestational diabetes mellitus (GDM) status (Kim et al., 2014). Since both hyperglycemia 
and diabetes management begin earlier during pregnancy for women with PDM, it is 
important to understand the burden of large birth size attributable to excess GWG among 
women with PDM for early intervention. The purpose of this analysis was to examine the 
percentage of LGA and macrosomic births attributable to excess GWG, independent of 
prepregnancy BMI, among women who have PDM.
2. Methods
We analyzed full-term (37–41 weeks) live, singleton deliveries occurring from March 2004 
through December 2008 to women aged 20 or more years using Florida’s revised 2003 U.S. 
Standard Certificate of Live Birth linked to the state’s Hospital Inpatient Discharge Database 
(N = 746,328). Birth records were linked to maternal inpatient hospitalizations through a 
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multistage, stepwise approach that has been described elsewhere (Salemi et al., 2013). All 
hospitals in Florida, except for military and Veterans Administration institutions, are 
represented. The Florida Department of Health transferred de-identified data to the Centers 
for Disease Control and Prevention (CDC) for analysis. Because there were no identifiers, an 
Institutional Review Board of the CDC determined approval was not needed because CDC 
was not engaged in human subjects’ research.
2.1. Maternal characteristics
Diabetes status in pregnancy was determined by using both the birth certificate and the 
hospital discharge data. On the birth certificate, diabetes is recorded as prepregnancy 
(diagnosis before this pregnancy), gestational (diagnosis during this pregnancy), or none. 
Only one selection is allowed. On the hospital discharge record, diabetes is identified by the 
following International Classification of Diseases, 9th Revision, Clinical Modification 
(ICD9-CM) codes: 648.8 (abnormal glucose tolerance (gestational diabetes)); 648.0 
(diabetes mellitus); or 250.0–250.9 (diabetes mellitus (excludes gestational diabetes)). We 
used a previous medical record review of a small subset of the pregnancies to formulate 
rules for assigning PDM status (Kim et al., 2012): PDM cases were defined as deliveries in 
which the hospital discharge record included the ICD9-CM codes for preexisting diabetes 
(648.0 and 250.0–250.9) regardless of birth certificate status as that gave the highest 
specificity. Pregnancies without diabetes were those for which both the hospital discharge 
record and birth certificate indicated no diabetes (neither preexisting nor gestational).
We used birth certificate data to obtain additional information on maternal characteristics 
including age, educational attainment, marital status, race/ethnicity, insurance status, parity, 
smoking status, birth country, height, prepregnancy weight, weight at delivery, and 
enrollment in the Special Supplemental Nutrition Program for Women, Infants, and Children 
(WIC). Prepregnancy BMI (prepregnancy weight in kilograms/height in meters2) was 
calculated, and women were classified as underweight (BMI < 18.5 kg/m2), normal weight 
(BMI 18.5–24.9 kg/m2), overweight (BMI 25.0–29.9 kg/m2), class I obese (BMI 30.0–34.9 
kg/m2), class II obese (BMI 35–39.9 kg/m2), or class III obese (BMI ≥ 40.0 kg/m2). GWG, 
calculated as the difference between weight at delivery and prepregnancy weight, was used 
to categorize women with inadequate, appropriate, or excess GWG based on the 2009 IOM 
recommendations (IOM (Institute of Medicine) & NRC (National Research Council), 2009). 
Appropriate GWG was defined as 28–40 lb for underweight women, 25–35 lb for normal 
weight women, 15–25 lb for overweight women, and 11–20 lb for obese women (regardless 
of obesity class).
LGA was defined as birthweight >90th percentile for gestational age based on the 
distribution of birth weights in Florida recorded on birth certificates from 2004 to 2008. 
Gestational age was calculated using the obstetric estimate also as recorded on the birth 
certificate. Macrosomia was defined as birth weight >4500 g.
2.2. Inclusion and exclusion criteria
Records with no missing data on diabetes status and indicated either no diabetes in both data 
sources or PDM on hospital discharge were eligible for the study (n = 697,872). Births 
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where hospital discharge indicated GDM (n = 37,620), birth certificate indicated PDM or 
GDM but hospital discharge indicated no diabetes (n = 8503), or hospital discharge records 
indicated both PDM and GDM (n = 147) were not eligible.
We also excluded records missing values on birth weight or extreme values (<1000 or >7257 
g) (n = 50), missing prepregnancy BMI including those with implausible or extreme 
maternal height (<4′2″ or >6′5″), weight (<75 lb) (n = 42,071), missing GWG (n = 
48,998), or nativity (n = 280). Our final analytic sample included 92.0% of our eligible study 
population, or 641,857 births. There were differences between those eligible but excluded 
compared to those included; notably, those excluded had a lower proportion of LGA and 
macrosomia but no difference in the proportion of PDM (Supplemental Table 1). Although 
the proportion of inadequate gestational weight gain was higher, the majority of women 
were missing data on this variable.
2.3. Statistical analysis
We examined maternal demographic characteristics and birth outcomes by diabetes status. 
We also examined the prevalence of LGA and macrosomia by GWG adequacy among 
women who had PDM. We present LGA prevalence by GWG adequacy and BMI categories. 
Cell sizes <20 could not be reported; therefore, we only present prevalence of macrosomia 
among women with excess GWG by BMI category. We computed relative risks (RR) and 
95% confidence intervals (CI) for LGA among those who gained excess and inadequate 
GWG according to methods described by Flanders and Rhodes (Flanders & Rhodes, 1987) 
with appropriate GWG as the referent group. This RR estimate produces a marginal RR 
based on logistic regression fit to the data. Using the adjusted logistic regression methods 
described by Graubard & Fears (2005), we then estimated the adjusted population 
attributable fraction (PAF) of LGA and macrosomic births to PDM mothers with excess 
GWG. We interpreted each PAF estimate to be the reduction in LGA or macrosomia 
prevalence that would be expected if all women who had excess GWG had an LGA risk 
equal to that of women who had appropriate GWG, assuming that the risk for LGA among 
those with appropriate GWG remained unchanged (Levine, 2008). We adjusted for 
prepregnancy BMI, maternal age, race/ethnicity and parity in the logistic models and PAF 
because they have been shown to be independently associated with GWG and LGA 
(Weissmann-Brenner et al., 2012; Deputy et al., 2015).
3. Results
Maternal characteristics and birth outcomes by diabetes status are shown in Table 1. Overall, 
excess GWG was 51.2%. Compared to women without diabetes, a higher proportion of 
women with PDM were older, less educated, non-Hispanic black, enrolled in WIC, parous, 
obese, and had GWG outside of recommendations (Table 1). LGA and macrosomia 
prevalence overall was 9.5% and 0.9%, respectively (Fig. 1); stratified by diabetes status, 
LGA and macrosomia prevalence among women with no diabetes was 9.4% and 0.9% and 
among women with PDM was 28.8% and 5.8%, respectively. Among women with no PDM, 
LGA prevalence by GWG adequacy was 4.0%, 6.4%, and 13.0% for inadequate, 
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appropriate, and excess GWG, respectively, whereas, among women with PDM, LGA 
prevalence by GWG adequacy was 19.0%, 20.9%, and 36.0% (Fig. 1).
LGA prevalence was highest among PDM women who experienced excess GWG and were 
obese (Table 2). A similar pattern was observed for macrosomia (data not shown). Among 
women with no diabetes and excess GWG, the prevalence of macrosomia was 1.1%, 1.5%, 
and 2.0% for normal weight, overweight, and obese women, respectively. Prevalence of 
macrosomia increased to 5.8%, 7.3%, and 8.9%, respectively, for women with PDM and 
excess GWG.
Among women with PDM, the relative risk of LGA was 1.7 (95% CI 1.5, 1.9) for excess 
GWG and 0.9 (95% CI 0.8, 1.1) for inadequate GWG compared to appropriate gain, 
controlling for prepregnancy BMI and other covariates (Table 3). The PAF of LGA 
attributable to excess GWG was 27.7% (95% CI 22.0, 33.3). Similarly, the adjusted relative 
risk of macrosomia was 2.1 (95% CI 1.5, 2.9) for excess GWG and 0.8 (95% CI 0.5, 1.3) for 
inadequate GWG compared to appropriate gain. The PAF of macrosomia attributable to 
excess GWG was 38.6% (95% CI 24.9, 52.4). Adjustments did not change any of the crude 
estimates.
4. Discussion
Our study demonstrates that independent of prepregnancy BMI, as much as 27.7% of LGA 
and 38.6% of macrosomia among children born to women with PDM might be prevented if 
these women gained gestational weight within IOM recommendations. More than half of 
women in the study had excess GWG, which is similar to other population-based reports in 
the US (Deputy et al., 2015). Among women with PDM, prevalence of LGA was 29% and 
increased to 36% among women who gained excess GWG. Others have reported similar 
LGA estimates ranging from 30.1% to 42.1% among women with PDM who had excess 
GWG (Scifres et al., 2014; Siegel et al., 2015b). Prevalence of macrosomia among women 
with PDM in our study was 5.8% and increased to 7.9% in those with excess GWG.
The positive association between GWG and fetal growth is well documented (IOM (Institute 
of Medicine) & NRC (National Research Council), 2009) and confirmed in our study. 
Current GWG guidelines are based on balancing the risks of too little or too much GWG in 
the average healthy population but these guidelines do not differ by diabetes status (IOM 
(Institute of Medicine) & NRC (National Research Council), 2009). There is limited 
evidence on the range of GWG that balances risk of small for gestational age (SGA) and 
LGA among women with PDM. A recent, albeit small, study of women with both obesity 
and type 2 diabetes found that those who gained 5 kg or less, compared to those who gained 
>5 kg, had fewer LGA infants and no difference in SGA infants, regardless of gestational 
age (Asbjornsdottir et al., 2013). Another study examining women with obesity and any 
diabetes found a significant reduction of LGA risk among term (≥39 weeks gestation) 
infants, but only in women with GWG less than the recommended 11–20 lb and class III 
obesity. Term SGA risk increased, but was not statistically significant. Among the women 
with class I and II obesity and any diabetes, lower gestational weight gains did not 
significantly reduce the risk of LGA or increase the risk of SGA (Gavard & Artal, 2014). 
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These two studies are similar to our results in that we did not observe a statistically 
significant lower risk of LGA with inadequate gain compared to appropriate gain 
(Asbjornsdottir et al., 2013; Gavard & Artal, 2014). However, more evidence is needed to 
determine if a lower range of GWG is appropriate for women specifically with PDM within 
each BMI category. Nonetheless, it is important for women with diabetes to not have excess 
GWG.
In 2009–2012, among women 20–44 year of age in the U.S., 1.6% have diagnosed diabetes 
with an additional 1.7% having undiagnosed diabetes (National Center for Health Statistics, 
2014). Among pregnant women, <1% had PDM (Bardenheier et al., 2015). Although the 
prevalence of preexisting diabetes is low, the maternal and fetal implications are concerning 
given the risk of stillbirth, congenital anomalies, and excess fetal growth. Maintaining 
glycemic control before and during pregnancy is important as studies have shown a positive 
association between maternal glucose levels and fetal growth (Metzger et al., 2008). 
Therefore, providing appropriate preconception care to women with diabetes is an important 
opportunity to help them achieve optimal glucose control prior to becoming pregnant. In 
addition, screening for diabetes early in pregnancy among high risk women is another 
opportunity to diagnose diabetes and provide appropriate interventions early to maintain 
glycemic control and limit GWG. The American College of Obstetricians and Gynecologists 
(ACOG) recommends early pregnancy screening for undiagnosed type 2 diabetes in women 
with risk factors such as prior history of GDM and obesity (Anon., 2013a). The Endocrine 
Society recommends universal screening for undiagnosed diabetes in early pregnancy with 
either a fasting plasma glucose, untimed random plasma glucose, or hemoglobin A1C 
(Blumer et al., 2013).
Although we cannot prevent PDM in pregnancy, excess GWG among women with PDM can 
be prevented. ACOG recommends that clinicians educate all women on the importance of 
appropriate GWG and counsel women on proper dietary behaviors and physical activity to 
achieve recommended GWG (Anon., 2013b). Furthermore, it is recommended that 
management of diabetes in pregnancy is focused on proper glucose control using a careful 
combination of diet, exercise, and insulin therapy (ACOG Practice Bulletin, 2005). ACOG 
encourages PDM patients to keep a log of diet, insulin dosages, exercise, and glucose values 
to help them manage their glucose control (ACOG Practice Bulletin, 2005). Since weight 
gain has been shown to be a common problem with intensive insulin regimens (Scholl TO & 
Chen, 2002), women with PDM may benefit from additional care by a registered dietician 
who can provide an individualized nutrition program to achieve the appropriate carbohydrate 
and insulin balance needed to avoid excess GWG. We have limited population-level 
estimates on how much information patients receive from clinicians regarding GWG using 
the most recent IOM guidelines. However, recent research has shown that improving 
clinician knowledge and effort to address appropriate GWG has been effective in helping 
women gain within IOM recommendations (Lindberg et al., 2016; Wilkinson et al., 2016). 
In addition, strategies such as meeting dietary and physical activity goals have been shown 
to help women gain within IOM recommendations (Muktabhant et al., 2015). There are 
limited studies assessing whether interventions targeting patient education on GWG can lead 
to measurable improvements. Therefore, it is important for healthcare providers to provide 
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advice consistent with current IOM guidelines and be knowledgeable in proper referrals to 
develop individualized physical activity and nutrition plans.
Our study used a large, racially and ethnically diverse, population-based database to examine 
the population burden of LGA and macrosomia attributable to excess GWG. However, the 
analysis has limitations. Although our database was large and diverse, we still had a small 
sample-size to examine macrosomia by GWG and BMI. GWG was calculated using 
prepregnancy weight and weight at delivery from the birth certificate. Since self-reported 
prepregnancy weight may be underreported (Park et al., 2011), both BMI and GWG may be 
misclassified with BMI being underestimated and GWG being overestimated. Second, we 
may have underestimated the prevalence of PDM, given that sensitivity for ascertaining 
PDM hospital discharge data may be as low as 47.1% (Devlin et al., 2008). Furthermore, 
although our study is observational, we assumed a causal association between GWG and 
large birth size in order to calculate the PAF, as there is a large body of evidence that is 
strong and shows a large magnitude of association (IOM (Institute of Medicine) & NRC 
(National Research Council), 2009). By definition, the PAF is estimated to be the reduction 
in LGA or macrosomia prevalence that would occur if all women who had excess GWG had 
an LGA or macrosomia risk equal to that of women who gained appropriate GWG. Third, 
we do not have data on glycemic control, which may confound the relationship between 
GWG (through insulin use) and large birth size. However, a recent study indicated that the 
increase in LGA and macrosomia risk among women with PDM who had excess GWG was 
not explained by glycemic control (Siegel et al., 2015a). Fourth, we did not have any 
information on diet, physical activity, and other behavior and lifestyle factors that may 
influence gestational weight gain. Future studies should include these factors if available. 
Finally, our findings may not be generalizable to women outside of Florida. However, 
Florida is the fourth most populous U.S. state and is racially and ethnically diverse. Further, 
the LGA prevalence was similar to national average (Donahue et al., 2010).
5. Conclusion
Infants born too large increase risk for adverse maternal and infant health outcomes 
including delivery and neonatal complications as well as long-term morbidities in the infant 
such as obesity and diabetes (Johnsson et al., 2015). As much as one-third of macrosomia 
among women with PDM may be explained by excess GWG; thus, targeted prevention 
efforts to reduce excess GWG are needed.
Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.ypmed.
2016.08.026.
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Prevalence of large for gestational age (LGA) and macrosomia infants overall, by diabetes 
status, and by gestational weight gain status (GWG), Florida, 2004–2008. Large for 
gestational age (LGA); diabetes mellitus (DM); preexisting diabetes mellitus (PDM); 
gestational weight gain (GWG). LGA: defined as ≥90th percentile; macrosomia defined as 
>4500 g. Includes only mothers with a full-term (37–41 weeks) singleton, live birth.
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Table 1
Maternal characteristics and birth outcomes by diabetes statusa, Florida, 2004–2008, %.
No diabetes (N = 637,430) Preexisting diabetes mellitus (N = 4427) P-value
Overall % 99.3 0.7
Age <0.0001
 20–29 60.6 43.4
 30–39 36.6 50.8
 40+ 2.7 5.8
Education <0.0001
 <12 12.9 14.4
 12 30.9 32.8
 >12 55.9 52.5
Race/ethnicity <0.0001
 Non-Hispanic White 52.6 46.1
 Non-Hispanic Black 19.6 28.8
 Hispanic 25.1 21.8
 Asian/Pacific Islander 2.7 3.3
 WIC status <0.0001
 Yes 40.1 49.5
 No 59.0 50.1
Insurance status <0.0001
 Medicaid 40.8 43.3
 Private insurance 51.6 51.7
 Self-pay 5.8 3.5
 Other 1.6 1.2
Parity <0.0001
 0 38.1 33.8
 1 34.7 34.1
 2+ 26.8 31.8
Smoking during pregnancy 7.6 7.7 0.5825
Nativity <0.0001
 U.S. 73.1 75.8
 Foreign 27.0 24.2
BMI <0.0001
 <18.5 4.9 1.2
 18.5–24.9 52.0 23.5
 25.0–29.9 24.0 22.4
 30.0–34.9 11.3 21.4
 35.0–39.9 4.8 14.8
 ≥40.0 3.0 16.7
Gestational weight gain <0.0001
 Inadequate 17.2 18.4
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No diabetes (N = 637,430) Preexisting diabetes mellitus (N = 4427) P-value
 Appropriate 31.6 27.5
 Excess 51.2 54.1
LGA >90th percentile 9.4 28.8 <0.0001
Macrosomia 4500 g 0.9 5.8 <0.0001
a
Included only mothers 20 years or older with a full-term (37–41 weeks) live, singleton birth.
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Table 3
Relative risk and population attributable fraction of LGA and macrosomia for excess gestational weight gain.
LGA Macrosomia
Relative risk (95% CI)a 1.7 (1.5, 1.9) 2.1 (1.5, 2.9)
Population attributable fraction (95% CI)a 27.7% (22.0, 33.3) 38.6% (24.9, 52.4)
a
Adjusted for prepregnancy BMI, maternal age, race/ethnicity, and parity.
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